How much did ResMed's stock rise after the announcement?

The stock rose 3.7% in the afternoon session following the announcement.

Why did Goldman Sachs add ResMed to the list?

No specific reason was given, but analysts point to growing demand for sleep apnea devices in Asia.

Does being on the list guarantee future stock gains?

No, inclusion boosts confidence but does not guarantee future performance. Fundamentals should be assessed.

ResMed Added to Goldman Sachs APAC Conviction List

Goldman Sachs added ResMed (RMD) to its Asia-Pacific Conviction List, sending the stock up 3.7% in afternoon trading, signaling renewed confidence from the investment bank.

July 3, 2026

2 min read

Source: StockStory

Key Numbers

stock gain

3.7%

Shares of medical device company ResMed (NYSE:RMD) jumped 3.7% in the afternoon session after it was added to Goldman Sachs' APAC Conviction List, signaling renewed confidence from the investment bank.

Details of the Inclusion

Goldman Sachs placed ResMed on its curated list of top stock picks for the Asia-Pacific region. The list typically includes stocks that analysts expect to outperform over the long term.

Rationale Behind the Upgrade

While Goldman Sachs did not provide detailed commentary, analysts note that ResMed benefits from rising demand for sleep apnea devices, particularly in Asian markets where health awareness is growing.

Stock Performance

Prior to this announcement, RMD shares had declined about 8% over the past month, making the inclusion a positive catalyst for investor sentiment.

What This Means for Investors

Being added to Goldman Sachs' Conviction List can boost institutional confidence, but it does not guarantee future performance. Investors should monitor the company's financial reports and fundamentals before making decisions.

Frequently Asked Questions

The Conviction List is a curated set of stocks that Goldman Sachs analysts strongly recommend, expecting them to outperform over the long term.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.